Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Published:2020-05 Issue:5 Volume:15 Page:860-866
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Domblides Charlotte,Leroy Karen,Monnet Isabelle,Mazières Julien,Barlesi Fabrice,Gounant Valérie,Baldacci Simon,Mennecier Bertrand,Toffart Anne-Claire,Audigier-Valette Clarisse,Doucet Ludovic,Giroux-Leprieur Etienne,Guisier Florian,Ricordel Charles,Molinier Olivier,Perol Maurice,Pichon Eric,Robinet Gilles,Templement-Grangerat Dorine,Ruppert Anne-Marie,Rabbe Nathalie,Antoine Martine,Wislez Marie

Funder

Merck

French ANR

Roche

Merck Sharp & Dohme

AstraZeneca

Bristol-Myers Squibb

Fonds de Recherche en Santé Respiratoire

Fondation du Souffle

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung;Vieira;Lung Cancer,2014

2. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma;Vieira;J Thorac Oncol,2013

3. Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities;Pécuchet;Ann Oncol,2017

4. MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung;Saffroy;Oncotarget,2017

5. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages;Vieira;Lung Cancer,2016

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors;European Journal of Cancer;2024-09

2. Sintilimab combined with anlotinib as first-line treatment for advanced sarcomatoid carcinoma of head and neck: a case report and literature review;Frontiers in Oncology;2024-04-24

3. Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes;Cancer Innovation;2024-04-15

4. Case report: Pathological complete response induced by immunochemotherapy in a case of Pulmonary Sarcomatoid Carcinoma staged IIIA-N2;Frontiers in Immunology;2024-04-08

5. Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non–small cell lung cancer;Journal of Pathology and Translational Medicine;2024-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3